Neurol. pro Praxi, 2003; 1: 35-37

Dopaminergní léčba a její vliv na sexuální dysfunkce u pacientů s Parkinsonovou nemocí

MUDr. Michal Pohanka1, prof. MUDr. Petr Kaňovský CSc2, MUDr. Jiří Pulkrábek3
1 Sexuologické oddělení LF MU, FN u sv. Anny v Brně
2 Neurologická klinika FN a LF UP Olomouc
3 I. neurologická klinika LF MU a FN u sv. Anny Brno

Keywords: Parkinsonova nemoc, sexuální dyfunkce, dopaminergní terapie.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pohanka M, Kaňovský P, Pulkrábek J. Dopaminergní léčba a její vliv na sexuální dysfunkce u pacientů s Parkinsonovou nemocí. Neurol. praxi. 2003;4(1):35-37.

Sexuální dysfunkce postihují většinu pacientů trpících Parkinsonovou nemocí, muže i ženy, a to až u 50-70% nemocných. Spektrum poruch je velmi široké, od ztráty apetence, snížení libida, až po vyhasnutí erektilní funkce nebo neschopnost vaginální lubrikace. Klasická sexuologická léčba často selhává, zejména u žen, kde nelze použít léky k léčbě erektilní dysfunkce, jako je např. sildenafil. Dopaminergní medikace, tj. podávání L-DOPA nebo agonistů dopaminu, se však ukazuje mít pozitivní účinek na tyto invalidizující symptomy Parkinsonovy nemoci. Zároveň však je schopna vyvolat u některých pacientů hypersexualitu. Tyto efekty dopaminergní medikace je potřeba znát a cíleně s nimi pracovat, zejména ve skupinách mladších pacientů se zachovanou sexuální aktivitou, nebo u těch, kteří se o zachování snaží.

Download citation

References

  1. Brown E, Brown GM, Kofman O, Quarrington B. Sexual function and affect in parkinsonian men treated with L-DOPA. Am J Psychiatr 1978; 135: 1552-1555. Go to original source... Go to PubMed...
  2. Brown RG, Jahanshahi M, Quinn N, Marsden CD. Sexual dysfunction in patients with Parkinson´s disease and their partners. J Neurol Neurosurg Psychiatr 1990; 53: 480-486. Go to original source... Go to PubMed...
  3. Wermuth L, Stenager E. Sexual problems in young patients with Parkinson´s disease. Acta Neurol Scand 1995; 91: 453-455. Go to original source... Go to PubMed...
  4. Lambert D, Waters CH. Sexual dysfunction in Parkinson´s disease. Clin Neurosci 1998; 5: 73-77. Go to PubMed...
  5. Posen J, Moore O, Tassa DS, Ginzburg K, Drory M, Giladi N. Young women with PD: a group work experience. Soc Work Helat Care 2000; 32: 77-91. Go to original source... Go to PubMed...
  6. Moore O, Gurevich T, Korczyn AD, Anca M, Shabtai H, Giladi N. Quality of sexual life in Parkinson´s disease. Parkinsonism Relat Disord 2002; 8: 243-246. Go to original source... Go to PubMed...
  7. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989; 12: 375-383. Go to original source... Go to PubMed...
  8. Weinman E, Ruskin PE. Levodopa dependence and hypersexuality in older Parkinson´s disease patients. Am J Ger Psych 1995; 3: 81-83. Go to original source...
  9. Cummings JL. Behavioral complications of drug treatment in Parkinson´s disease. J Am Ger Soc 1991; 39: 708-716. Go to original source... Go to PubMed...
  10. Rosen RC, Ashton AK. Prosexual drugs: empirical status of the, ,new aphrodisiacs". Arch Sex Behav 1993; 22: 521-543. Go to original source... Go to PubMed...
  11. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995; 19: 19-38. Go to original source... Go to PubMed...
  12. O´Sullivan JD, Hughes AJ. Apomorphine-induced penile erections in Parkinson´s disease. Mov Disord 1998; 13: 536-539. Go to original source... Go to PubMed...
  13. Fine J, Lang AE. Dose-induced penile erections in response to ropinirole therapy for Parkinson´s disease. Mov Disord 1999, 14: 701-702. Go to original source... Go to PubMed...
  14. Jimenez-Jimenez FJ, Tallon-Barranco A. Fluctuating penile erections related with levodopa therapy. Neurology 1999; 52: 210-212. Go to original source... Go to PubMed...
  15. Kaňovský P, Bareš M, Pohanka M, Rektor I. Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson´s disease. J Neurol 2002; 249: 112-114. Go to original source... Go to PubMed...
  16. Raffaele R, Vecchio I, Giamusso B, Morgia G, Brunetto MB, Rampello L. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson´s disease. Eur Urol 2002, 41; 382-386. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.